Recent Posts
- New Multicenter Study Highlights Use of the NavDx® Test in Resolving Clinically Indeterminate Findings
- Naveris to Present New Data Highlighting Clinical Utility of the NavDx® Test at the 2024 ASCO Annual Meeting
- Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer
- Naveris Awarded ADLT Status by CMS for the NavDx® Test
- Naveris Announces New Data at EUROGIN International Multidisciplinary HPV Congress 2024
Recent Comments